iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in iBio, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +18 vs. Q3 2025
- Shares held
- 16.3M
- +12.8M (+357.7%) vs. Q3 2025
- Total value
- $31.6M
- +$28.6M (+967.7%) vs. Q3 2025
- New holders
- 26
- 12 more added
- Sold out
- 8
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 55 | $60.8M |
| Q1 2026 | 52 | $36.9M |
| Q4 2025 | 50 | $31.6M |
| Q3 2025 | 32 | $2.96M |
| Q2 2025 | 30 | $2.44M |
| Q1 2025 | 34 | $10.4M |
| Q4 2024 | 30 | $6.40M |
| Q3 2024 | 32 | $5.79M |
| Q2 2024 | 28 | $5.68M |
| Q1 2024 | 28 | $11.5M |
| Q4 2023 | 21 | $344.6K |
| Q3 2023 | 29 | $269.9K |
| Q2 2023 | 29 | $695.7K |
| Q1 2023 | 30 | $3.45M |
| Q4 2022 | 38 | $1.02M |
| Q3 2022 | 46 | $4.97M |
| Q2 2022 | 57 | $7.63M |
| Q1 2022 | 77 | $17.5M |
| Q4 2021 | 83 | $25.0M |
| Q3 2021 | 90 | $47.6M |
| Q2 2021 | 87 | $65.5M |
| Q1 2021 | 94 | $68.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding iBio, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Motiv8 Investments LLC | 1 | $0 | 0.00% | +1 | New |
| Wells Fargo & Company | 1 | $2 | 0.00% | −3−75.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $4 | 0.00% | +2 | New |
| Activest Wealth Management | 4 | $8 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 5 | $10 | 0.00% | 00.0% | Unchanged |
| SOA Wealth Advisors, LLC. | 13 | $25 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 22 | $42 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 91 | $112 | 0.00% | 00.0% | Unchanged |
| SHP Wealth Management | 60 | $116 | 0.00% | +60 | New |
| Advisor Group Holdings, Inc. | 384 | $741 | 0.00% | −320−45.5% | Reduced |
| Fortitude Family Office, LLC | 431 | $832 | 0.00% | +431 | New |
| Tower Research Capital LLC (TRC) | 1,380 | $2.66K | 0.00% | −353−20.4% | Reduced |
| Citigroup Inc | 5,046 | $9.74K | 0.00% | +5,046 | New |
| JustInvest LLC | 12,491 | $24.1K | 0.00% | +12,491 | New |
| PFG Investments, LLC | 21,500 | $41.5K | 0.00% | +21,500 | New |
| Morgan Stanley | 27,595 | $53.3K | 0.00% | +27,538+48,312.3% | Added |
| XTX Topco Ltd | 37,014 | $71.4K | 0.00% | +37,014 | New |
| Persistent Asset Partners Ltd | 39,585 | $76.4K | 0.04% | +39,585 | New |
| Northern Trust Corp | 40,314 | $77.8K | 0.00% | +17,270+74.9% | Added |
| BlackRock, Inc. | 42,727 | $82.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 72,899 | $140.7K | 0.00% | +39,200+116.3% | Added |
| Mountain Capital Investment Advisors, Inc | 63,000 | $141.8K | 0.02% | +63,000 | New |
| Jane Street Group, LLC | 105,700 | $204.0K | 0.00% | +105,700 | New |
| Silverarc Capital Management, LLC | 106,000 | $204.6K | 0.03% | +106,000 | New |
| Two Sigma Advisers, LP | 108,400 | $209.2K | 0.00% | +108,400 | New |
| Bank of America Corp | 115,793 | $223.5K | 0.00% | +115,648+79,757.2% | Added |
| Marshall Wace, LLP | 121,286 | $234.1K | 0.00% | +121,286 | New |
| UBS Group AG | 126,556 | $244.3K | 0.00% | +126,555+12,655,500.0% | Added |
| Jefferies Financial Group Inc. | 160,000 | $308.8K | 0.00% | +160,000 | New |
| Walleye Capital LLC | 198,375 | $382.9K | 0.00% | +198,375 | New |
| Geode Capital Management, LLC | 222,610 | $429.6K | 0.00% | +71,301+47.1% | Added |
| Noesis Capital Mangement Corp | 224,200 | $432.7K | 0.06% | +224,200 | New |
| Hudson Bay Capital Management LP | 242,076 | $467.2K | 0.00% | +242,076 | New |
| Boothbay Fund Management, LLC | 254,412 | $491.0K | 0.01% | +77,550+43.8% | Added |
| Monashee Investment Management LLC | 274,862 | $530.5K | 0.30% | +274,862 | New |
| Renaissance Technologies LLC | 353,339 | $681.9K | 0.00% | +353,339 | New |
| ADAR1 Capital Management, LLC | 405,531 | $782.7K | 0.06% | +378,531+1,402.0% | Added |
| Two Sigma Investments, LP | 456,333 | $880.7K | 0.00% | +456,333 | New |
| Ameriprise Financial Inc | 584,368 | $1.13M | 0.00% | +102,068+21.2% | Added |
| Sio Capital Management, LLC | 740,000 | $1.43M | 0.24% | +740,000 | New |
| Vanguard Group Inc | 883,149 | $1.70M | 0.00% | +609,079+222.2% | Added |
| Ikarian Capital, LLC | 957,062 | $1.85M | 0.24% | +339,735+55.0% | Added |
| Balyasny Asset Management LLC | 1,096,179 | $2.12M | 0.00% | +1,085,779+10,440.2% | Added |
| Frazier Life Sciences Management, L.P. | 1,953,467 | $3.77M | 0.10% | +1,953,467 | New |
| Logos Global Management LP | 2,000,000 | $3.86M | 0.26% | +2,000,000 | New |
| Affinity Asset Advisors, LLC | 2,057,200 | $3.97M | 0.29% | +2,057,200 | New |
| EcoR1 Capital, LLC | 2,228,000 | $4.30M | 0.20% | +2,228,000 | New |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −1,055,897−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −131,958−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −45,079−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −44,471−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −41,900−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,157−100.0% | Sold out |
| City Holding Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |